35 related articles for article (PubMed ID: 22744707)
1. Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights.
Iesato A; Li S; Roti G; Hacker MR; Fischer AH; Nucera C
J Clin Endocrinol Metab; 2021 Nov; 106(12):3569-3590. PubMed ID: 34302727
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin Inhibits the Progression of Obesity-Associated Papillary Thyroid Carcinoma Through Autophagy.
Li C; Zhang J; Dionigi G; Liang N; Guan H; Sun H
Endocrinology; 2024 Mar; 165(5):. PubMed ID: 38492235
[TBL] [Abstract][Full Text] [Related]
3. Potential significance of podoplanin immunohistochemical expression in papillary thyroid carcinoma.
Khalil RM; El Badawy NM; Osman WM; Shash LS; Hafez FS
Pol J Pathol; 2023; 74(3):171-181. PubMed ID: 37955536
[TBL] [Abstract][Full Text] [Related]
4. Stimulated Raman Scattering Microscopy Reveals Aberrant Triglyceride Accumulation in Lymphatic Metastasis of Papillary Thyroid Carcinoma.
Zeng J; Wu G; Jia H; Liu C; Liu C; Zhang Y; Liu S; Wang J; Yue S
Anal Chem; 2024 Apr; 96(15):5735-5740. PubMed ID: 38567982
[TBL] [Abstract][Full Text] [Related]
5. Elevated Levels of Interleukin-18 are Associated with Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Chun W; Lu M; Chen J; Li J
Horm Metab Res; 2024 Feb; ():. PubMed ID: 38354749
[TBL] [Abstract][Full Text] [Related]
6. Lysyl Oxidase Promotes the Formation of Vasculogenic Mimicry in Gastric Cancer through PDGF-PDGFR Pathway.
Liu Y; Sun B; Lin Y; Deng H; Wang X; Xu C; Wang K; Yu N; Liu R; Han M
J Cancer; 2024; 15(7):1816-1825. PubMed ID: 38434983
[No Abstract] [Full Text] [Related]
7. BCL9 is a Risk Factor of Neck Lymph Nodes Metastasis and Correlated with Immune Cell Infiltration in Papillary Thyroid Carcinoma.
Zhang R; Gui Z; Zhao J; Zhao L
Int J Gen Med; 2024; 17():1451-1466. PubMed ID: 38645401
[TBL] [Abstract][Full Text] [Related]
8. Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer.
Kim Y; Yun HJ; Choi KH; Kim CW; Lee JH; Weicker R; Kim SM; Park KC
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003602
[TBL] [Abstract][Full Text] [Related]
9. CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in
Duangdara J; Boonsri B; Sayinta A; Supradit K; Thintharua P; Kumkate S; Suriyonplengsaeng C; Larbcharoensub N; Mingphruedhi S; Rungsakulkij N; Muangkaew P; Tangtawee P; Vassanasiri W; Suragul W; Janvilisri T; Tohtong R; Bates DO; Wongprasert K
Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38275995
[TBL] [Abstract][Full Text] [Related]
10. Computational evidence for multi-layer crosstalk between the cadherin-11 and PDGFR pathways.
Karagöz Z; Passanha FR; Robeerst L; van Griensven M; LaPointe VLS; Carlier A
Sci Rep; 2023 Sep; 13(1):15804. PubMed ID: 37737289
[TBL] [Abstract][Full Text] [Related]
11. Heart failure as first sign of development of cardiac metastases in a patient with diagnosis of papillary thyroid carcinoma on treatment with tyrosine-kinase inhibitors: differential diagnoses and clinical management.
Bruixola G; Segura A; Caballero J; Andrés A; Reche E; Escoín C; Díaz-Beveridge R
Case Rep Oncol; 2014 May; 7(2):591-9. PubMed ID: 25298765
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of PDGFR-α for wound age determination.
Zhang W; Ishida Y; Nosaka M; Kuninaka Y; Ishigami A; Yasuda H; Kofuna A; Kamata T; Goto U; Kondo T
Int J Legal Med; 2024 Mar; ():. PubMed ID: 38520552
[TBL] [Abstract][Full Text] [Related]
13. Correction: CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases.
Liu W; Wei W; Winer D; Bamberger A-; Bamberger C; Wagener C; Ezzat S; Asa SL
Oncogene; 2023 Oct; 42(42):3159-3160. PubMed ID: 37704785
[No Abstract] [Full Text] [Related]
14. Platelet-derived growth factor receptor-α promotes lymphatic metastases in papillary thyroid cancer.
Zhang J; Wang P; Dykstra M; Gelebart P; Williams D; Ingham R; Adewuyi EE; Lai R; McMullen T
J Pathol; 2012 Oct; 228(2):241-50. PubMed ID: 22744707
[TBL] [Abstract][Full Text] [Related]
15. Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial-mesenchymal transition.
Ekpe-Adewuyi E; Lopez-Campistrous A; Tang X; Brindley DN; McMullen TP
Oncotarget; 2016 Dec; 7(50):83684-83700. PubMed ID: 27845909
[TBL] [Abstract][Full Text] [Related]
16. Autocrine activation of platelet-derived growth factor receptor α in metastatic papillary thyroid cancer.
Adewuyi EE; Deschenes J; Lopez-Campistrous A; Kattar MM; Ghosh S; McMullen TPW
Hum Pathol; 2018 May; 75():146-153. PubMed ID: 29408504
[TBL] [Abstract][Full Text] [Related]
17. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
[TBL] [Abstract][Full Text] [Related]
18. Surgical Management of Lymph Node Compartments in Papillary Thyroid Cancer.
Sturgeon C; Yang A; Elaraj D
Surg Oncol Clin N Am; 2016 Jan; 25(1):17-40. PubMed ID: 26610772
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.
Randolph GW; Duh QY; Heller KS; LiVolsi VA; Mandel SJ; Steward DL; Tufano RP; Tuttle RM;
Thyroid; 2012 Nov; 22(11):1144-52. PubMed ID: 23083442
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
